THE MEDICINES PATENT POOL IMPROVES ACCESS TO AFFORDABLE AND APPROPRIATE ESSENTIAL MEDICINES IN LOW- AND MIDDLE-INCOME COUNTRIES.
scroll down to find out how
THE MEDICINES PATENT POOL IMPROVES ACCESS TO AFFORDABLE AND APPROPRIATE HIV, HEPATITIS C AND TUBERCULOSIS MEDICINES IN LOW- AND MIDDLE-INCOME COUNTRIES.
IT DOES THIS BY ADDRESSING A KEY CHALLENGE IN EQUITABLE ACCESS TO TREATMENT – THE NEED FOR MULTIPLE SOURCES OF AFFORDABLE, QUALITY ASSURED MEDICINES FOR USE IN DEVELOPING COUNTRIES.
SHARING TECHNOLOGY AND PATENTS IS KEY
PATENTS REWARD INNOVATION AND IF LICENSED WIDELY, THEY CAN SPUR THE DEVELOPMENT OF A COMPETITIVE MARKET AND FURTHER INNOVATION TO MEET SPECIFIC DEVELOPING COUNTRY NEEDS.
The MPP partners with stakeholders through a voluntary licensing and patent pooling model.VIEW OUR STAKEHOLDERS
help MPP identify treatment needs
The World Health Organization works with the MPP to prioritise medicines and forecast future uptake
Patent holders agree to license their medicines to the MPP
THE MPP LICENSES RIGHTS TO MANUFACTURE THESE TREATMENTS TO GENERIC PHARMACEUTICAL COMPANIES
LICENSING TERMS ENCOURAGE THE SALE OF LOW-COST VERSIONS IN MORE THAN A HUNDRED DEVELOPING COUNTRIES
MANUFACTURES CAN ALSO COMBINE DIFFERENT MEDICINES TO PRODUCE FIXED-DOSE COMBINATIONS
...two or three treatments in one pill
...and special formulations for children.
NEW TREATMENTS BECOME AVAILABLE FASTER IN DEVELOPING COUNTRIES